We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$104M
Cap. Flow
+$114M
Cap. Flow %
52.89%
Top 10 Hldgs %
3.25%
Holding
1,960
New
575
Increased
592
Reduced
190
Closed
602

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$919K
2
ALXO icon
ALX Oncology
ALXO
+$905K
3
EYPT icon
EyePoint Inc
EYPT
+$814K
4
MGNX icon
MacroGenics
MGNX
+$773K
5
CMPS
Compass Pathways
CMPS
+$725K

Top Sells

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$394K
2
RIOT icon
Riot Platforms
RIOT
+$366K
3
REVG
REV Group
REVG
+$362K
4
TSHA icon
Taysha Gene Therapies
TSHA
+$353K
5
PBYI icon
Puma Biotechnology
PBYI
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 15.83%
3 Industrials 15.4%
4 Financials 12.94%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFC icon
1851
Truist Financial
TFC
$63.1B
– –
-2,815
Closed -$110K
TJX icon
1852
TJX Companies
TJX
$145B
– –
-1,175
Closed -$119K
TMO icon
1853
Thermo Fisher Scientific
TMO
$227B
– –
-16
Closed -$9.3K
TMUS icon
1854
T-Mobile US
TMUS
$195B
– –
-253
Closed -$41.3K
TPG icon
1855
TPG
TPG
$8.78B
– –
-485
Closed -$21.7K
TPH
1856
DELISTED
Tri Pointe Homes
TPH
– –
-5,346
Closed -$207K
TPR icon
1857
Tapestry
TPR
$24.4B
– –
-963
Closed -$45.7K
TRC icon
1858
Tejon Ranch
TRC
$444M
– –
-14,740
Closed -$227K
TRMK icon
1859
Trustmark
TRMK
$2.71B
– –
-1,835
Closed -$51.6K
TRV icon
1860
Travelers Companies
TRV
$77B
– –
-13
Closed -$2.99K
TSHA icon
1861
Taysha Gene Therapies
TSHA
$1.82B
– –
-122,905
Closed -$353K
TSLA icon
1862
Tesla
TSLA
$1.4T
– –
-670
Closed -$118K
TSLX icon
1863
Sixth Street Specialty
TSLX
$1.75B
– –
-1,641
Closed -$35.2K
TTD icon
1864
Trade Desk
TTD
$6.78B
– –
-1,467
Closed -$128K
TWIN icon
1865
Twin Disc
TWIN
$344M
– –
-2,183
Closed -$36.1K
TYRA icon
1866
Tyra Biosciences
TYRA
$1.71B
– –
-1,345
Closed -$22.1K
U icon
1867
Unity
U
$18.3B
– –
-2,418
Closed -$64.6K
UE icon
1868
Urban Edge Properties
UE
$2.65B
– –
-9,877
Closed -$171K
UEC icon
1869
Uranium Energy
UEC
$5.71B
– –
-4,340
Closed -$29.3K
UGP icon
1870
Ultrapar
UGP
$7.76B
– –
-10,056
Closed -$57.5K
UHS icon
1871
Universal Health Services
UHS
$10B
– –
-101
Closed -$18.4K
UI icon
1872
Ubiquiti
UI
$35.1B
– –
-735
Closed -$85.2K
UL icon
1873
Unilever
UL
$138B
– –
-123
Closed -$6.93K
UMC icon
1874
United Microelectronic
UMC
$52.1B
– –
-1,738
Closed -$14.1K
UNH icon
1875
UnitedHealth
UNH
$356B
– –
-151
Closed -$74.7K
73 74
75
76 77

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
T
TOBAM Paris, France $412M AUM 18.33% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return

EntryPoint Capital's Q2 2024 Portfolio in Review

As of Q2 2024, EntryPoint Capital held 1,960 positions worth $215M, up 93% from $112M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

EntryPoint Capital deployed $114M of net new capital in Q2 2024, opening 575 new positions and adding to 592 existing holdings. Its largest new stake was EyePoint Inc: 58,291 shares worth $507K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Oscar Health, an estimated $327K trimmed.

  • EntryPoint Capital's largest Q2 2024 buy was EyePoint Inc: 58,291 shares worth $507K.
  • EntryPoint Capital added most to Photronics in Q2 2024, an estimated $919K increase.
  • EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
  • EntryPoint Capital fully exited Sutro Biopharma in Q2 2024, selling an estimated $394K.
  • EntryPoint Capital's ten largest holdings make up 3.3% of its $215M portfolio in Q2 2024.
  • EntryPoint Capital opened 575 new positions and closed 602 in Q2 2024.
  • EntryPoint Capital's portfolio value rose 93% quarter-over-quarter to $215M.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.